Challenges and successes for the grantees and the Technical Advisory Group of WHO’s influenza vaccine technology transfer initiative-Reference-Cited by-同舟云学术

Challenges and successes for the grantees and the Technical Advisory Group of WHO’s influenza vaccine technology transfer initiative

Published:2016-10 Issue:45 Volume:34 Page:5420-5424
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Grohmann Gary,Francis Donald P.,Sokhey Jaspal,Robertson James

Funder

Biomedical Advanced Research and Development Authority

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference14 articles.

1. World Health Organization. Sixty-fourth World Health Assembly (WHA64.5). Pandemic influenza preparedness: sharing of influenza viruses and access to vaccines and other benefits. ; 2011[accessed 20.06.16].

2. World Health Organization. WHO’s Global Influenza Surveillance and Response System (GISRS). ; 2016 [accessed 20.06.16].

3. World Health Organization. Global pandemic influenza action plan to increase vaccine supply. ; 2006 [accessed 20.06.16].

4. WHO influenza vaccine technology transfer initiative: role and activities of the technical advisory group;Francis;Vaccine,2011

5. An international technology platform for influenza vaccines;Hendriks;Vaccine,2011

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vaccine technology transfer in a global health crisis: Actors, capabilities, and institutions;Research Policy;2023-05

2. Technology transfer programme for influenza vaccines – Lessons from the past to inform the future;Vaccine;2022-08

3. Global production capacity of seasonal and pandemic influenza vaccines in 2019;Vaccine;2021-01

4. R&D for Emerging Infectious Diseases of Epidemic Potential: Sharing Risks and Benefits Through a New Coalition;Infectious Diseases in the New Millennium;2020

5. Safety and immunogenicity of a seasonal trivalent inactivated split influenza vaccine: a double blind, phase III randomized clinical trial in healthy Serbian adults;Therapeutic Advances in Vaccines and Immunotherapy;2020-01